US20250339549A1
University of Texas System
Provided are methods of treating a cancer that co-expresses one or more placental alkaline phosphatase (ALPP) proteins and a cancer target antigen in a patient in need thereof, comprising administering to the patient a treatment regimen wherein the treatment regimen comprises administration of one …